Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Uveitis-Associated Cystoid Macular Edema
NCT00000115Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Dec 1990
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of acetazolamide in cystoid macular edema (CME) (2 arms), sponsored by National Eye Institute. Primary endpoints: Reduction in Cystoid Macular Edema at 4 weeks and Best Corrected Visual Acuity at 4 weeks. Started Dec 1990; status: completed.
02
Drugs
acetazolamide
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00000115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000115.